ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,108Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 761

$505K Total Retail Price of All Prescriptions

Rank: 125 out of 761

494 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,661 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 560 531 1 2
LISINOPRIL 461 409 2 1
LEVOTHYROXINE SODIUM 438 418 3 3
OMEPRAZOLE 433 332 4 4
HYDROCODONE-ACETAMINOPHEN 375 319 S3 5 5
AMLODIPINE BESYLATE 320 297 6 6
ATORVASTATIN CALCIUM 301 282 7 12
FUROSEMIDE 241 201 8 7
LOSARTAN POTASSIUM 232 230 9 13
POTASSIUM CHLORIDE 210 170 10 18
ATENOLOL 197 194 11 8
METFORMIN HCL 164 149 12 10
METOPROLOL SUCCINATE 163 156 13 16
WARFARIN SODIUM 162 138 14 9
GABAPENTIN 161 129 15 15
HYDROCHLOROTHIAZIDE 160 140 16 11
SERTRALINE HCL 154 126 17 25
ZOLPIDEM TARTRATE 152 133 18 22
METOPROLOL TARTRATE 150 146 19 14
CITALOPRAM HBR 143 129 20 19
TRAZODONE HCL 143 126 20 23
LOVASTATIN 132 120 22 17
OXYCODONE HCL 115 96 S2 23 24
LOSARTAN-HYDROCHLOROTHIAZIDE 110 108 24 65
ALLOPURINOL 101 91 25 28
VENLAFAXINE HCL ER 93 66 26 76
CARVEDILOL 93 83 26 26
TAMSULOSIN HCL 86 85 28 27
FENOFIBRATE 86 77 28 91
ALENDRONATE SODIUM 79 75 30 21
DONEPEZIL HCL 74 74 31 33
LANTUS 73 73 32 41
CYCLOBENZAPRINE HCL 72 23 R 33 51
TRIAMTERENE-HCTZ 72 67 33 42
PANTOPRAZOLE SODIUM 70 58 35 40
CLONIDINE HCL 70 70 35 69
ZETIA 69 67 37 87
FLUTICASONE PROPIONATE 67 61 38 29
PAROXETINE HCL 66 56 39 47
PRAVASTATIN SODIUM 66 60 39 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 43 41 35
DIGOXIN 59 59 42 43
ROPINIROLE HCL 58 44 43 95
TRAMADOL HCL 58 57 43 34
PROAIR HFA 56 31 45 32
CIPROFLOXACIN HCL 56 50 45 63
NEXIUM 55 55 47 98
CLOPIDOGREL 54 54 48 66
FLUOXETINE HCL 54 45 48 31
ISOSORBIDE MONONITRATE ER 53 52 50 72
SINGULAIR 51 41 51 138
KLOR-CON 10 51 43 51 74
ADVAIR DISKUS 50 50 53 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.